BEAT
HeartBeam, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.42
−3.90%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.44
From 52W high−87.82%
Volume734319.00
Market cap$23.61M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataOct 19, 2026
Open
$0.44
From 52W high
−87.82%
Volume
734319.00
Market cap
$23.61M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.7x
P/E (TTM)
—
RSI (14)
46.6
MomentumView details →
1D Return
−3.90%
YTD Return
−82.50%
SummaryUpdated Jun 1, 2026
HeartBeam, Inc. (NASDAQ:BEAT) is a medical technology company founded in 2015 and headquartered in Santa Clara, California. The company went public in November 2021 and focuses on developing innovative telemedicine solutions for cardiac monitoring and diagnosis outside traditional healthcare facility settings. HeartBeam has developed proprietary technology that enables the creation of a credit card-sized, cable-free electrocardiogram (ECG) device capable of synthesizing a full 12-lead ECG reading, representing a significant advancement in portable cardiac monitoring technology.
Similar companies
Latest newsMore news →
HeartBeam, Inc. joined the European EXIT-CVD research consortium to advance at-home ECG monitoring for early detection of acute coronary syndrome in high-risk patients.5d agoHeartBeam received FDA Breakthrough Device Designation for its heart attack assessment technology.15d agoHeartBeam completed enrollment of 120 patients in its ALIGN-ACS pilot study evaluating its portable 3D ECG technology for potential heart-attack detection.33d ago